Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 47,455 full-time employees. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Quels sont les états financiers clés de Takeda Pharmaceutical Company Limited ?
Selon le dernier état financier (Form-10K), Takeda Pharmaceutical Company Limited a un total d'actifs de $0, un bénéfice net 손실 de $0
Quels sont les ratios financiers clés pour TAK ?
Le ratio de liquidité de Takeda Pharmaceutical Company Limited est 0, la marge nette est 0, les ventes par action sont de $0.
Comment les revenus de Takeda Pharmaceutical Company Limited sont-ils répartis par segment ou géographie ?
Takeda Pharmaceutical Company Limited 주요 수익원은 Gastroenterology Revenue (Pre-FY2023 Reporting)이며, 최신 수익 발표에서 수익은 1,216,207,000,000입니다. 지역별로는 Japan이 Takeda Pharmaceutical Company Limited의 주요 시장이며, 수익은 433,110,000,000입니다.
Takeda Pharmaceutical Company Limited est-elle rentable ?
no, selon les derniers états financiers, Takeda Pharmaceutical Company Limited a un bénéfice net 손실 de $0
Takeda Pharmaceutical Company Limited a-t-elle des passifs ?
no, Takeda Pharmaceutical Company Limited a un passif de 0
Combien d'actions en circulation Takeda Pharmaceutical Company Limited a-t-elle ?
Takeda Pharmaceutical Company Limited a un total d'actions en circulation de 0